Exposure therapy is effective in about half of the patients with post-traumatic stress syndrome (PTSD). This percentage may possibly increase due to the targeted use of cortisol in the right patients. Benno Roozendaal received a TOP subsidy from ZonMw to investigate this. For this study he will collaborate with Erno Hermans, Robbert-Jan Verkes and Gert-Jan Hendriks.Posttraumatic stress disorder (PTSD) is a serious psychiatric disorder, characterized by uncontrollable anxiety reactions. The disorder can be the result of drastic traumatic events earlier in life, such as sexual or physical abuse or war experiences. Exposure therapy is a therapy where patients recall the trauma, while in a safe environment. In this way an attempt is made to permanently reduce the anxiety of the patient.
CortisolExposure therapy is one of the most common and effective treatments for PTSD. Nevertheless, it only works in about half of the patients. It’s unknown why it doesn’t work for others.
With the TOP grant, Benno Roozendaal and his colleagues will investigate whether the stress hormone cortisol can be used to predict the success of exposure therapy. Normally cortisol is released when someone ends up in a stressful situation. The hormone plays a role in the ability to respond well in the situation at hand.
Fear reductionRoozendaal: "In some patients we see a weak cortisol response, especially in patients who have experienced traumatic experiences in early childhood. Apparently something is wrong with their stress response. We are going to investigate that now, first of all in rats. We examine whether a weakened cortisol response in these animals indeed leads to a weaker reduction of the anxiety reaction.”
“If so, it becomes interesting to investigate whether cortisol can cause anxiety reduction in patients with PTSD. And even more specifically: whether that has an effect especially in patients with such a disturbed, weaker cortisol response.”
Related news items
The first Radboud Nanomedicine community networking event14 February 2019
On 7 February 2019 the first Radboud Nanomedicine community networking event took place. The goal of the event was to bring together all those working in the field of nanomedicine at the Radboud University and Radboudumc, irrespective of the theme in which the research is performed.read more
Research Integrity Round: The ConScience App 15 February 201914 February 2019
To introduce the new Netherlands Code of Conduct for Research Integrity we invited ‘Het Acteursgenootschap’ to perform ‘The ConScience App’, a theatre piece designed to move the debate on scientific knowledge. All Radboudumc researchers are invited to attend this event.read more
Gene involved in colorectal cancer also causes breast cancer14 February 2019
Judith Grolleman, Nicoline Hoogerbrugge and Richarda de Voer, theme Tumors of the digestive tract, published in Cancer Cell that mutations in the NTHL1 gene, previously associated with colorectal cancer, also cause breast cancer and other types of cancer.read more
Endometrial natural killer cells remember previous pregnancy11 February 2019
Dorien Feyaerts, theme Inflammatory diseases, showed that pregnancy induces a memory phenotype on endometrial natural killer cells. However, previous CMV infection is a prerequisite for this memory induction. They published their findings in Cellular and Molecular Immunology.read more
ZonMw TOP grant to uncover the dormancy of malaria parasites7 February 2019
Richard Bartfai, theme Infectious diseases and global health, and Clemens Kocken (BPRC) received 675,000 euros from ZonMw to uncover the molecular mechanisms underlying dormancy of malaria parasites, a major obstacle to efficient treatment of P. vivax malaria.read more
Prevalence of sexual harassment in academic medicine7 February 2019
In JAMA Internal Medicine Sabine Oertelt-Prigione described how sexual harassment is a pervasive phenomenon that can affect anyone in the workplace.read more